The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB–IIC Patients—Results After 3 Years

BACKGROUND: This study compares well-being, recurrences, and deaths of early-stage cutaneous melanoma patients in follow-up, as recommended in the Dutch guideline, with that of patients in a stage-adjusted reduced follow-up schedule, 3 years after diagnosis, as well as costs. METHODS: Overall, 180 e...

Descripción completa

Detalles Bibliográficos
Autores principales: Deckers, Eric A., Hoekstra-Weebers, Josette E. H. M., Damude, Samantha, Francken, Anne Brecht, ter Meulen, Sylvia, Bastiaannet, Esther, Hoekstra, Harald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Melanoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138761/
https://www.ncbi.nlm.nih.gov/pubmed/31535302
http://dx.doi.org/10.1245/s10434-019-07825-7

Ejemplares similares

Ejemplares similares